Lonza Group AG (LZAGF)
OTCMKTS
· Delayed Price · Currency is USD
582.25
+2.00 (0.34%)
Nov 21, 2024, 4:00 PM EST
Lonza Group AG Revenue
Lonza Group AG had revenue of 3.06B CHF in the half year ending June 30, 2024, with 2.52% growth. This brings the company's revenue in the last twelve months to 6.70B, up 5.97% year-over-year. In the year 2023, Lonza Group AG had annual revenue of 6.72B with 7.94% growth.
Revenue (ttm)
6.70B CHF
Revenue Growth
+5.97%
P/S Ratio
n/a
Revenue / Employee
372.00K CHF
Employees
18,000
Market Cap
42.52B USD
Revenue Chart
* This company reports financials in CHF.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 6.72B | 494.00M | 7.94% |
Dec 31, 2022 | 6.22B | 814.00M | 15.05% |
Dec 31, 2021 | 5.41B | 901.00M | 19.99% |
Dec 31, 2020 | 4.51B | 301.00M | 7.15% |
Dec 31, 2019 | 4.21B | -1.34B | -24.09% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sandoz Group AG | 10.11B |
Telix Pharmaceuticals Limited | 430.80M |
Elekta AB (publ) | 1.69B |
Ryman Healthcare Limited | 411.39M |
Verano Holdings Corp. | 897.57M |
Vireo Growth Inc. | 98.53M |
Medexus Pharmaceuticals Inc. | 104.76M |
Lonza Group AG News
- 4 weeks ago - Lonza Sees Accelerating Sales Growth in Final Quarter - The Wall Street Journal
- 2 months ago - Acumen Pharmaceuticals extends collaboration with Lonza - Seeking Alpha
- 2 months ago - Acumen Pharmaceuticals Extends Collaboration with Lonza to Add Drug Product Manufacturing of Sabirnetug for Early Alzheimer's Disease - Benzinga
- 4 months ago - Lonza Group AG (LZAGY) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 6 months ago - Lonza Group AG (LZAGY) Q1 2024 Earnings Call Transcript - Seeking Alpha
- 8 months ago - Lonza: Acceleration In Mid-Term Sales Growth - Seeking Alpha
- 10 months ago - Lonza: Excellent Growth Projections Will Sharply Increase Free Cash Flow - Seeking Alpha
- 10 months ago - Lonza Group AG (LZAGY) Q4 2023 Earnings Call Transcript - Seeking Alpha